Iranian Journal of Pharmaceutical Sciences (IJPS) - Keyword Index

Home Keyword Index

Volume 12 (2016)

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 

A

A172; Volume 12, Issue 1, 2016, Page 35-44
A172; Volume 12, Issue 4, 2016, Page 55-62
A2780; Volume 12, Issue 1, 2016, Page 11-20
A2780; Volume 12, Issue 1, 2016, Page 35-44
A2780; Volume 12, Issue 4, 2016, Page 55-62
A2780-CP; Volume 12, Issue 1, 2016, Page 11-20
Acetic acid; Volume 12, Issue 3, 2016, Page 17-30
ACMS; Volume 12, Issue 3, 2016, Page 65-74
Activatory effects; Volume 12, Issue 1, 2016, Page 35-44
Activatory effects; Volume 12, Issue 4, 2016, Page 55-62
Allium sativum; Volume 12, Issue 3, 2016, Page 1-10
Ambulatory care; Volume 12, Issue 4, 2016, Page 63-68
Angiogenesis; Volume 12, Issue 1, 2016, Page 59-68
Anti-angiogenic Activity; Volume 12, Issue 1, 2016, Page 59-68
Anti-cancer activity; Volume 12, Issue 4, 2016, Page 15-32
Antioxidant; Volume 12, Issue 1, 2016, Page 1-10
Apigenin; Volume 12, Issue 2, 2016, Page 21-32
Apium; Volume 12, Issue 2, 2016, Page 21-32
Arum conophalloides; Volume 12, Issue 3, 2016, Page 11-16

B

Bioautography; Volume 12, Issue 2, 2016, Page 1-8
Bioequivalence; Volume 12, Issue 4, 2016, Page 1-14
Bioequivalence Study; Volume 12, Issue 1, 2016, Page 21-34
Boswellic Acid; Volume 12, Issue 4, 2016, Page 15-32
Brain anomaly; Volume 12, Issue 2, 2016, Page 75-84
Buthotus schach; Volume 12, Issue 3, 2016, Page 55-64
Bypassing agents; Volume 12, Issue 2, 2016, Page 85-90

C

CAM assay; Volume 12, Issue 1, 2016, Page 59-68
Cannabis sativa; Volume 12, Issue 3, 2016, Page 1-10
Carbon paste; Volume 12, Issue 1, 2016, Page 45-58
Casticin; Volume 12, Issue 1, 2016, Page 59-68
Catalase; Volume 12, Issue 1, 2016, Page 85-96
Cefixime; Volume 12, Issue 4, 2016, Page 1-14
Cell Proliferation; Volume 12, Issue 1, 2016, Page 35-44
Cell Proliferation; Volume 12, Issue 4, 2016, Page 55-62
Central composite design; Volume 12, Issue 4, 2016, Page 77-92
Clopidogrel; Volume 12, Issue 2, 2016, Page 43-60
Clopidogrel; Volume 12, Issue 2, 2016, Page 61-74
Conventional treatments; Volume 12, Issue 4, 2016, Page 33-42
Cosmos; Volume 12, Issue 2, 2016, Page 21-32
Cost components; Volume 12, Issue 2, 2016, Page 85-90
Cost-effectiveness analysis; Volume 12, Issue 4, 2016, Page 33-42
Crospovidone; Volume 12, Issue 2, 2016, Page 61-74
Current Clamp; Volume 12, Issue 3, 2016, Page 55-64
Cytotoxicity; Volume 12, Issue 1, 2016, Page 1-10

D

Date; Volume 12, Issue 1, 2016, Page 35-44
Developmental toxicity; Volume 12, Issue 2, 2016, Page 75-84
Dexamethasone; Volume 12, Issue 4, 2016, Page 63-68
Disintegration Time; Volume 12, Issue 2, 2016, Page 61-74

E

E. coli; Volume 12, Issue 2, 2016, Page 33-42
Economic evaluation; Volume 12, Issue 4, 2016, Page 33-42
Enalapril; Volume 12, Issue 1, 2016, Page 21-34
Enalaprilate; Volume 12, Issue 1, 2016, Page 21-34
Endothelial cell; Volume 12, Issue 3, 2016, Page 1-10
Enzymatic lyses; Volume 12, Issue 2, 2016, Page 33-42
Essential oil composition; Volume 12, Issue 3, 2016, Page 11-16

F

Factorial design; Volume 12, Issue 4, 2016, Page 77-92
Ferula gummosa; Volume 12, Issue 1, 2016, Page 85-96
Fickian Diffusion; Volume 12, Issue 2, 2016, Page 61-74
Flavoxate; Volume 12, Issue 1, 2016, Page 45-58
Flux; Volume 12, Issue 2, 2016, Page 9-20
Formulation; Volume 12, Issue 4, 2016, Page 77-92

G

Gastroesophageal reflux disease; Volume 12, Issue 4, 2016, Page 69-76
GC/MS; Volume 12, Issue 3, 2016, Page 11-16
Gel Filteration; Volume 12, Issue 3, 2016, Page 55-64
Gender; Volume 12, Issue 4, 2016, Page 63-68

H

Halomonas; Volume 12, Issue 2, 2016, Page 33-42
Hardness; Volume 12, Issue 4, 2016, Page 1-14
Hawthorn; Volume 12, Issue 4, 2016, Page 69-76
Heartburn; Volume 12, Issue 4, 2016, Page 69-76
Hemophilia; Volume 12, Issue 2, 2016, Page 85-90
HFFF2; Volume 12, Issue 1, 2016, Page 35-44
HFFF2; Volume 12, Issue 4, 2016, Page 55-62
HPLC; Volume 12, Issue 1, 2016, Page 69-84
HPLC; Volume 12, Issue 2, 2016, Page 21-32
Human plasma; Volume 12, Issue 1, 2016, Page 21-34

I

ICH; Volume 12, Issue 2, 2016, Page 43-60
Imatinib; Volume 12, Issue 1, 2016, Page 69-84
Incremental cost-effectiveness ratio; Volume 12, Issue 4, 2016, Page 33-42
Infliximab; Volume 12, Issue 4, 2016, Page 33-42
Inhibitor; Volume 12, Issue 2, 2016, Page 85-90
Intracellular; Volume 12, Issue 2, 2016, Page 33-42
Invivo study; Volume 12, Issue 1, 2016, Page 59-68
Ionone; Volume 12, Issue 3, 2016, Page 11-16
Iran; Volume 12, Issue 2, 2016, Page 85-90
Isolated mitochondria; Volume 12, Issue 2, 2016, Page 75-84
Isolated rat liver; Volume 12, Issue 1, 2016, Page 69-84

J

K

Kermanshah; Volume 12, Issue 3, 2016, Page 11-16

L

L-asparaginase; Volume 12, Issue 2, 2016, Page 33-42
LC; Volume 12, Issue 2, 2016, Page 43-60
LC-MS; Volume 12, Issue 1, 2016, Page 21-34

M

Malondialdehyde; Volume 12, Issue 1, 2016, Page 85-96
Mercaptopurine; Volume 12, Issue 3, 2016, Page 65-74
Metabolism; Volume 12, Issue 1, 2016, Page 69-84
Mitochondria; Volume 12, Issue 3, 2016, Page 65-74
Montelukast Sodium; Volume 12, Issue 4, 2016, Page 15-32
Mouse fetus; Volume 12, Issue 2, 2016, Page 75-84
MTT assay; Volume 12, Issue 4, 2016, Page 15-32

N

Nanodispersion; Volume 12, Issue 4, 2016, Page 77-92
Nanoemulsion; Volume 12, Issue 3, 2016, Page 75-93
Nebivolol hydrochloride; Volume 12, Issue 2, 2016, Page 9-20
Neurobehavioral toxicity; Volume 12, Issue 2, 2016, Page 75-84
Nigella sativa; Volume 12, Issue 3, 2016, Page 1-10
Nitric Oxide; Volume 12, Issue 3, 2016, Page 1-10

O

Olea europaea L; Volume 12, Issue 4, 2016, Page 55-62
Olive; Volume 12, Issue 4, 2016, Page 55-62
Omeprazole; Volume 12, Issue 2, 2016, Page 43-60
Outlier; Volume 12, Issue 3, 2016, Page 47-54
Ovarian Cancer; Volume 12, Issue 1, 2016, Page 11-20

P

PC-3 cell line; Volume 12, Issue 4, 2016, Page 15-32
PDA; Volume 12, Issue 2, 2016, Page 43-60
Perfusion; Volume 12, Issue 1, 2016, Page 69-84
Petroselinum crispum; Volume 12, Issue 2, 2016, Page 21-32
PFOS; Volume 12, Issue 2, 2016, Page 75-84
Pharmacokinetic; Volume 12, Issue 1, 2016, Page 21-34
Pharmacokinetic; Volume 12, Issue 1, 2016, Page 69-84
Pharmacokinetics; Volume 12, Issue 4, 2016, Page 1-14
Phase diagram, Brinzolamide, Ophthalmic delivery, Biological studies, Release efficiency; Volume 12, Issue 3, 2016, Page 75-93
Phenylephrine; Volume 12, Issue 3, 2016, Page 47-54
Phlomis kurdica; Volume 12, Issue 1, 2016, Page 1-10
Phoenix dactylifera L; Volume 12, Issue 1, 2016, Page 35-44
Potentiometry; Volume 12, Issue 1, 2016, Page 45-58
Prescribing pattern; Volume 12, Issue 4, 2016, Page 63-68

Q

R

Rat; Volume 12, Issue 1, 2016, Page 85-96
Reactive Oxygen Species; Volume 12, Issue 3, 2016, Page 65-74
Regurgitation; Volume 12, Issue 4, 2016, Page 69-76
Respiratory infections; Volume 12, Issue 4, 2016, Page 63-68
Response surface methodology; Volume 12, Issue 4, 2016, Page 77-92
Reversed-phase HPLC. dissulotion; Volume 12, Issue 4, 2016, Page 1-14
Root; Volume 12, Issue 1, 2016, Page 85-96
RU486; Volume 12, Issue 4, 2016, Page 43-54

S

Scorpion Toxin; Volume 12, Issue 3, 2016, Page 55-64
Sesbania grandiflora; Volume 12, Issue 3, 2016, Page 31-46
SKMEL-3 cells; Volume 12, Issue 1, 2016, Page 1-10
Sonication; Volume 12, Issue 2, 2016, Page 33-42
SRB assay; Volume 12, Issue 4, 2016, Page 15-32
Superoxide dismutase; Volume 12, Issue 1, 2016, Page 85-96
Syrup; Volume 12, Issue 4, 2016, Page 69-76

T

Tablets; Volume 12, Issue 4, 2016, Page 1-14
TLC; Volume 12, Issue 2, 2016, Page 1-8
Trigonella foenum-graecum; Volume 12, Issue 3, 2016, Page 1-10
Tyrosinase; Volume 12, Issue 1, 2016, Page 1-10

U

Ulcerative Colitis; Volume 12, Issue 4, 2016, Page 33-42

V

Vitex agnus castus; Volume 12, Issue 1, 2016, Page 59-68
Voltage Gated Na Channels; Volume 12, Issue 3, 2016, Page 55-64

W

Wetting Time; Volume 12, Issue 2, 2016, Page 61-74
Whole-Cell Patch Clamp; Volume 12, Issue 3, 2016, Page 55-64

X

Y

Z